Evan Berger
Retina Specialist · Norfolk, VANPI 1356769731
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.4%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Bausch & Lomb, A Division Of Bausch Health US, LLC accounts for 68.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,584 and has fallen 94.3% since, to $91 in 2024.
Across 43 payments — averaging $56.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb, A Division Of Bausch Health US, LLC$2K
- Notal Vision, Inc.$247
- AbbVie$146
- Abbott$118
- Regeneron Healthcare Solutions, Inc.$98
- Genentech USA, Inc.$68
- plus $83 from 4 others
What the payments were for
- Speaking & faculty fees$24710%
- Travel & lodging$1,14347%
- Food & beverage$1,02442%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 20 | $1,655 |
| Notal Vision, Inc. | 1 | $247 |
| AbbVie(2 entities) | 8 | $146 |
| Abbott | 1 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $98 |
| Genentech USA, Inc. | 4 | $68 |
| Dutch Ophthalmic, USA | 1 | $24 |
| Alimera Sciences, Inc. | 2 | $23 |
| Bausch & Lomb Americas Inc. | 1 | $18 |
| Novartis | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS PC$1,086
- LIGHT PIPES$1,086
- OPHTHALMIC INSTRUMENTS$1,086
- VITESSE$1,086
- PROCLAIM$118
How this compares
$2,415 in reported general payments places this provider in the 60th percentile of 41 retina specialist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 164 | $7,613 |
| Ketorolac Tromethamine | 97 | $2,321 |
| Brimonidine Tartrate | 85 | $1,631 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 63 | $862 |
| Difluprednate | 13 | $647 |
| Dorzolamide Hcl | 20 | $470 |
| Latanoprost | 45 | $422 |
| Gentamicin Sulfate | 33 | $374 |
| Timolol Maleate | 39 | $245 |
| ErythromycinErythromycin Base | 12 | $105 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Norfolk
- Jordana FeinManassas$412K
- Joaquin TosiVirginia Beach$48K
- Mohit NandaCharlottesville$31K
- Muge KesenMc Lean$30K
- Anna MackinRoanoke$26K
- Jon AdlebergChesapeake$21K
- Dal ChunVienna$12K
- Kori ElkinsPortsmouth$9K
- Jiwei ShengFairfax$8K
- Timothy ByrnesRoanoke$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.